$ALLT

Allot Ltd. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ALLT) 2026-05-15

Allot Ltd. (ALLT) published their Q1 2026 earnings call presentation, reporting an EPS of $0.06, beating estimates by $0.02, and revenue of $26.43M, exceeding expectations by $303.83K. The revenue marked a 14.15% year-over-year increase. This article presents the slide deck released concurrently with their Q1 earnings call.

Original reporting
Seeking Alpha · SA Transcripts
Published May 16, 2026, 12:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 16, 2026, 12:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ALLT
Neutral
high confidence
Mentioned
$ALLT
alphai data visualization · based on Seeking Alpha
Decision brief

The 30-second read

$ALLTNeutralMed
01

Why it matters

Strong Q1 results may boost investor confidence, but broader market conditions should be monitored.

02

Market read

The earnings report is highly relevant for traders focusing on the technology sector and NASDAQ-listed stocks.

03

What to watch

Potential macroeconomic headwinds or sector rotation could offset positive earnings impact.

Timing: Immediate, as earnings are recent and market reaction is ongoing.

Background

Allot Ltd. specializes in network intelligence and security solutions, with recent product launches and strategic partnerships.

Company-level read

Ticker impact

$ALLTNeutralHigh confidence
Context

Primary focus due to recent earnings report.

Expected impact

Moderate positive movement expected in the short term.

Evidence & confidence

Earnings beat estimates and revenue growth suggest positive investor sentiment, likely leading to upward price adjustment.

Market effects

Potential positive impact on the technology sector, especially companies with similar business models.

Limited, as the company operates primarily in its specific markets.

Moderate, given the company's NASDAQ listing and international investor interest.

Counterpoint

Market may have already priced in the earnings beat, leading to limited upside or potential short-term profit-taking.

Key entities

  • Allot Ltd.

    A provider of network intelligence and security solutions.

  • NASDAQ

    Stock exchange where ALLT is listed.

Related articles

$ALLTMed

Allot (ALLT) Q2 2026 Earnings Call Transcript

Allot (ALLT) reported Q2 2026 revenue of $27.7M, up 15% YoY, with SECaaS revenue at $9.4M, up 47% YoY. North America revenue grew to 31% of total, driven by strong demand for Tera III and smart products. The company raised and narrowed 2026 revenue guidance to $115M-$118M, citing accelerating growth and profitability. The board approved a $40M share purchase program, reflecting confidence in the company's strategy and financial strength.

$ALLTMed

Allot Ltd. Q2 2026 Earnings Call Summary

Allot Ltd. reported a fourth straight quarter of double-digit growth, citing North America strength and SECaaS scaling. SECaaS revenue rose 47% YoY to over one-third of total revenue. The company raised 2026 revenue guidance to $115m–$118m and expects 40%+ SECaaS growth, targeting ~70% gross margin and continued cash flow improvement. It also authorized a $40m share repurchase.

$ALLTMed

Allot Ltd (ALLT) (Q2 2026) Earnings Call Highlights: Revenue Surges 15%

Allot Ltd (ALLT) reported Q2 2026 earnings call highlights. Management said revenue rose 15% and strength came from both CCaaS and its smart product line. CEO Eyal Harari said backlog remains at a very high level. CFO Liat Nahum cited deferred revenue increasing by $7.5M QoQ plus $13.4M from Q1, improving visibility for 2026-27, and discussed a share buyback.

$ALLTHigh

Allot Ltd. (ALLT): Financial results for Q2 2026

Allot Ltd. (ALLT) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Allot Announces Second Quarter 2026 Financial Results Raising 2026 revenue guidance to $115–$118 million Hod Hasharon, Israel – August 12, 2026 – Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative Security-as-a-Service (SECaaS) and network

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.